Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mercer

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Lysosomal Enhancement Prevents Infection with PrP<sup>Sc</sup>, α-Synuclein & Tau PrionsRobert C C Mercer, Nhat T T Le, Nadia A Mirza-Romero, et al.
The Journal of Biological Chemistry|December 14, 2025
Enhanced lysosomal activity prevents infection with PrP<sup>Sc</sup> and the seeding activity of α-synuclein & tau prionsRobert C C Mercer, Nhat T T Le, Nadia A Mirza-Romero, et al.
EMBO Molecular Medicine|February 10, 2015
Octarepeat region flexibility impacts prion function, endoproteolysis and disease manifestationAgnes Lau, Alex McDonald, Nathalie Daude, et al.
Molecular Therapy. Methods & Clinical Development|September 24, 2025
Directed evolution of liver-detargeted AAV vectors for systemic gene delivery to skeletal muscle and heartElad Firnberg, Sigmund K S Tejada, Samantha A Yost, et al.
Plos Pathogens|January 17, 2018
A novel Gerstmann-Sträussler-Scheinker disease mutation defines a precursor for amyloidogenic 8 kDa PrP fragments and reveals N-terminal structural changes shared by other GSS allelesRobert C C Mercer, Nathalie Daude, Lyudmyla Dorosh, et al.
Journal of Virology|October 16, 2023
Characterization and biodistribution of under-employed gene therapy vector AAV7Samantha A Yost, Emre Firlar, Justin D Glenn, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Lysosomal Enhancement Prevents Infection with PrP<sup>Sc</sup>, α-Synuclein & Tau PrionsRobert C C Mercer, Nhat T T Le, Nadia A Mirza-Romero, et al.
The Journal of Biological Chemistry|December 14, 2025
Enhanced lysosomal activity prevents infection with PrP<sup>Sc</sup> and the seeding activity of α-synuclein & tau prionsRobert C C Mercer, Nhat T T Le, Nadia A Mirza-Romero, et al.
EMBO Molecular Medicine|February 10, 2015
Octarepeat region flexibility impacts prion function, endoproteolysis and disease manifestationAgnes Lau, Alex McDonald, Nathalie Daude, et al.
Molecular Therapy. Methods & Clinical Development|September 24, 2025
Directed evolution of liver-detargeted AAV vectors for systemic gene delivery to skeletal muscle and heartElad Firnberg, Sigmund K S Tejada, Samantha A Yost, et al.
Plos Pathogens|January 17, 2018
A novel Gerstmann-Sträussler-Scheinker disease mutation defines a precursor for amyloidogenic 8 kDa PrP fragments and reveals N-terminal structural changes shared by other GSS allelesRobert C C Mercer, Nathalie Daude, Lyudmyla Dorosh, et al.
Journal of Virology|October 16, 2023
Characterization and biodistribution of under-employed gene therapy vector AAV7Samantha A Yost, Emre Firlar, Justin D Glenn, et al.
BJU International|September 16, 2010
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT studyAnita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, et al.
Pageof 13